Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Cystic Fibrosis Blood Neutrophils

NCT04970225
unknownnot_applicable

Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer (CANEMESE)

NCT04836611
completed

Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)

NCT02065297

Clinical Trials (3)

Showing 3 of 3 trials
NCT04970225Not Applicable

Cystic Fibrosis Blood Neutrophils

Completed
NCT04836611Not Applicable

Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer (CANEMESE)

Unknown
NCT02065297

Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3